OKLAHOMA CCOP

俄克拉荷马州社区临床肿瘤学计划(CCOP)正在申请 由圣弗朗西斯医院和娜塔莉组成的财团 沃伦·布莱恩特癌症中心(NWBCC)；2)癌症护理协会(CCA)， 负责癌症项目开发的核心研究人员在 圣弗朗西斯二十多年；3)沃伦癌症研究 基金会(WCRF)。这项癌症计划目前在第十一年，因为 由基金资助的CCOP，以前称为圣弗朗西斯/NWBCC CCOP。这个 沃伦癌症研究基金会是 癌症研究计划，并将作为受赠人和财政 俄克拉荷马州CCOP的探员。预计公元11年的应计项目为80年。 患者接受治疗方案和60学分的癌症预防和 癌症控制研究。 圣弗朗西斯医院是一家拥有650个床位的非营利性教学医院，为 俄克拉荷马州东部超过150万居民以及190万人 堪萨斯州、密苏里州和阿肯色州邻近地区的居民。这个 俄克拉荷马州CCOP财团是该州唯一的CCOP，也是 该地区最大的癌症护理提供商，66.9%的 俄克拉荷马州东部的医疗保健市场。全部癌症患者 1998年预计将有2400名患者和28500人次就诊。 CCOP调查人员与ECOG有着长期的关系 (自1976年以来)，并与M.D.安德森和 NSABP分别于1986年和1988年。另一个从属关系是 与GOG于1997年8月成立。这些研究基地提供了一个 各种优秀的治疗试验以及前景看好的癌症 CCOP计划参与的预防和控制研究。 CCOP已将其近期目标定义为：增加应计利润 临床试验和预防/癌症控制研究；增加 参与临床试验的医疗保健提供者的范围；以及 提高公众对NCI批准的临床研究的认识，以改进 接受和认可这些努力。

The Oklahoma Community Clinical Oncology Program (CCOP) is applying as a consortium consisting of 1) Saint Francis Hospital and the Natalie Warren Bryant Cancer Center (NWBCC); 2) Cancer Care Associates (CCA), the core investigators responsible for cancer program development at Saint Francis for over twenty years; and 3) Warren Cancer Research Foundation (WCRF). This cancer program is currently in year eleven as a funded CCOP, previously known as the Saint Francis/NWBCC CCOP. The Warren Cancer Research Foundation serves as the administrative body for the cancer research program and will serve as the grantee and fiscal agent for the Oklahoma CCOP. The projected year 11 accrual is 80 patients on treatment protocols and 60 credits on cancer prevention and cancer control studies. Saint Francis Hospital is a 650 bed non-profit teaching hospital serving over 1.5 million residents of Eastern Oklahoma as well as 1.9 million residents in adjacent portions of Kansas, Missouri, and Arkansas. The Oklahoma CCOP Consortium is the only CCOP in the state and is the largest provider of cancer care in the area, capturing 66.9 percent of the healthcare market in Eastern Oklahoma. Total cancer patient accession is projected to be 2,400 patients and 28,500 visits for 1998. The CCOP Investigators have had a long-standing relationship with ECOG (since 1976) and established formal affiliations with M.D. Anderson and NSABP in 1986 and 1988, respectively. An additional affiliation was established with GOG in August, 1997. These research bases offer a variety of excellent treatment trials as well as promising cancer prevention and control studies in which the CCOP plans to participate. The CCOP has defined its immediate objectives as: increasing accrual in clinical trials and prevention/cancer control studies; increasing the range of healthcare providers participating in clinical trials; and increasing public awareness of NCI-approved clinical research to improve acceptance and endorsement of these efforts.